Syra Health Corp. SYRA
0.88
0.02
2.33%
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 90.0×
Follow SYRA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 5.18% | (7.60%) | (36.02%) | (45.71%) |
+8 more TTM periods Free account |
|
| 3.58% | (4.78%) | (27.79%) | (32.94%) | ||
ROIC |
9.15% | 0.00% | (116.91%) | (340.92%) | |
Return on Tangible Assets |
5.11% | (7.79%) | (43.29%) | (58.46%) | |
Average Days of Receivables |
66.32 | 41.51 | 46.39 | 45.09 | |
Free Cash Flow per Share |
0.01 | 0.06 | (0.04) | (0.03) | |
Free Cash Flow |
0.11 | 0.76 | (0.45) | (0.37) | |
Capital Expenditures |
— | — | (0.01) | — | |
Piotroski F-Score |
4.00 | 5.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
2.31% | 14.31% | (12.06%) | (8.92%) | |
Accounts Receivable Turnover |
6.87 | 8.42 | 9.04 | 8.28 | |
Accounts Payable Turnover |
13.04 | 13.80 | 27.14 | 19.86 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
14.55 | 28.03 | 19.07 | 22.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.68% | 0.49% | 0.94% | 0.83% | |
Selling, General and Administrative Expense of Revenue |
29.30% | 30.84% | 35.51% | 36.23% | |
Share Based Compensation of Revenue |
1.10% | 1.16% | 1.36% | 1.42% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | (4.13) | 0.50 | 0.29 | |
Depreciation/Fixed assets |
1.83 | 2.51 | 2.93 | 2.76 | |
Capex/Depreciation |
0.00 | 0.00 | (0.27) | 0.00 | |
Revenue per Share |
0.61 | 0.64 | 0.61 | 0.63 | |
Operating CF per Share |
0.01 | 0.06 | (0.04) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
1.62% | (2.40%) | (12.41%) | (16.89%) |
Columns are period end dates